Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001665:Binding Sites; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D003533:Cyproheptadine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D010868:Pimozide / Q000494:pharmacology; D011132:Polyribosomes / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D051381:Rats; D011955:Receptors, Drug; D012701:Serotonin / Q000378:metabolism*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004791:Enzyme Inhibitors; D011955:Receptors, Drug; D010868:Pimozide; D003533:Cyproheptadine; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine; D008784:Methysergide